Biofavi Tablet

About Biofavi 200 mg Tablet

Biofavi 200 mg Tablet is an antiviral medicine containing favipiravir, used for certain pandemic influenza virus infections when other influenza antiviral drugs are not effective enough. It is made by Biopharma Ltd.

There are 9 brands of Favipiravir listed in Bangladesh. By unit price, Biofavi is among the cheapest of them. The lowest listed price is Favivir 200 mg Tablet at ৳ 200.00 per unit.

What is Biofavi 200 mg Tablet?

Biofavi 200 mg Tablet is an antiviral medicine whose active ingredient is favipiravir. It belongs to the antiviral drug group and is prescribed for treating novel or re-emerging pandemic influenza virus infections, limited to cases where other influenza antiviral drugs are ineffective or not sufficiently effective. It works by blocking an enzyme the influenza virus needs to copy itself. Biofavi comes as a tablet in a 200 mg strength, supplied by Biopharma Ltd. in a 2 x 10 pack. Only a registered doctor can decide whether it is suitable for a particular patient.

Uses of Biofavi

Biofavi 200 mg Tablet is used to treat novel or re-emerging pandemic influenza virus infections. Its use is limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective. It is an antiviral medicine, not a general remedy for colds or other infections. A doctor assesses the infection and decides whether this medicine is appropriate. Do not start it on your own.

How to use Biofavi

Take Biofavi 200 mg Tablet exactly as your registered doctor directs. The dose, the number of times a day and the length of the course are decided by the doctor and may differ from person to person. Swallow the tablet as advised. Do not change the dose or stop early on your own, and ask your doctor or pharmacist if you are unsure how to take it.

Side effects of Biofavi

The most common side effects of favipiravir are diarrhea and a rise in blood uric acid levels. Blood uric acid changes are usually found through tests, so your doctor may monitor you. Contact your doctor if diarrhea is troublesome or if you notice any unusual symptom. Ask your doctor or pharmacist about anything you are worried about while taking Biofavi 200 mg Tablet.

Safety and precautions

Biofavi 200 mg Tablet must not be used during pregnancy, and women who may possibly be pregnant should not take it. Before use, women who could become pregnant need confirmation that they are not pregnant, and effective contraception is required from the start of treatment until a period after the end of treatment as advised by the doctor. Tell your doctor if you have liver or kidney problems. Keep the medicine below 30°C, protected from light and moisture, and out of reach of children.

Frequently asked questions

What does the dosage form and strength of Biofavi mean?

Biofavi is a tablet, which is a solid dosage form you swallow. The strength is 200 mg, meaning each tablet contains 200 mg of favipiravir. The pack is 2 x 10. Your doctor decides how the tablet is used in your case.

What is Biofavi 200 mg Tablet used for and what kind of medicine is it?

It is an antiviral medicine containing favipiravir. It is used for novel or re-emerging pandemic influenza virus infections, limited to cases where other influenza antiviral drugs are ineffective or not sufficiently effective. A doctor decides if it is right for you.

What side effects should I watch for, and when should I call the doctor?

The most common side effects are diarrhea and an increase in blood uric acid levels. Call your doctor if diarrhea is troublesome or if you notice any unusual symptom. Ask your doctor or pharmacist about any concern while taking this medicine.

What is the price of Biofavi 200 mg Tablet?

The listed price is ৳ 200.00.

Tablet
Generic name
Favipiravir
Strength
200 mg
Dosage form
Tablet
Manufactured by
Biopharma Ltd.
Price in Bangladesh

৳ 200.00 unit price

Price updated: 18 Nov 2026

Indications

Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).

Pharmacology

Favipiravir is a new antiviral drug against influenza. It is metabolized into favipiravir ribosyl triphosphate (favipiravir RTP) by an intracellular enzyme, and favipiravir RTP selectively inhibits RNA polymerase (RNA-dependent RNA polymerase) of the influenza virus, preventing replication of the influenza virus. It is a drug with a mechanism of action different from that of the existing influenza antiviral drugs and effective against all types and sub-types of human influenza A, B, and C viruses in vitro, showing a wide range of anti-viral activity against various influenza virus strains including avian and swine viruses.

Dosage & Administration

The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.

Interaction

In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.

Contraindications

Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.

Side Effects

Most common side effects are Diarrhea and increase of blood uric acid levels.

Pregnancy & Lactation

Favipiravir may cause delayed development or death of embryos during the early stage of pregnancy. Should not be given during pregnancy.

Precautions & Warnings

Favipiravir should not be given in pregnant women, requirement of the confirmation of non-pregnancy in women of childbearing potential before use, thorough contraception measures from the start of the treatment to 7 days after the end of the treatment. Caution should be taken for Hepatic and renal impaired patient or use Favipiravir as per the direction of registered Physician

Overdose Effects

In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.

Storage Conditions

Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Favipiravir

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.